期刊文献+

乳腺癌术后化疗致白细胞减少护理方法的观察

原文传递
导出
摘要 目的探讨乳腺癌术后辅助化疗致白细胞减少的有效治疗和护理方法。方法设立对照分析,两组均给予地榆升白片治疗,对照组实施化疗护理常规,观察组在对照组基础上实施血液系统疾病护理常规,对比观察疗效。结果经过临床治疗和精心护理,两组白细胞均恢复正常,使化疗如期进行;观察组感染发生率低于对照组。结论给予乳腺癌术后辅助化疗患者实施血液系统疾病护理常规护理,效果肯定,能够降低感染发生率。
出处 《中国城乡企业卫生》 2011年第6期64-65,共2页 Chinese Journal of Urban and Rural Enterprise Hygiene
  • 相关文献

参考文献7

二级参考文献58

  • 1陈莉颖,陈红风,付娜,叶媚娜.218例不同分子亚型浸润性乳腺癌患者的临床特征[J].现代肿瘤医学,2007,15(8):1094-1097. 被引量:12
  • 2Ejlertsen B, Mouridsen HT, Langkjer ST, et al. Phase Ⅲ study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG940a) [J].J Clin Oncol,2004,22(11):2313-2320.
  • 3Ryberg M, Nielsen D, Skovsgaard T, et al. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer[J]. J Clin Oncol, 1998,16(11):3502-3508.
  • 4Levine MN, Pritchard KI, Bramwell VH, et al. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5 [J].J Clin Oncol, 2005, 23 (22) : 5166- 5170.
  • 5Blomqvist C, Hietanen P, Teerenhovi L, et :al. Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study[J]. 1995,31A(13-14) :2406-2408.
  • 6Elling D, Eggemann H, Kummel S, et al. Adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel;epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study [J].Breast, 2003,12(3) :208-211.
  • 7Seidman AD. The emerging role of paclitaxel in breast cancer therapy[J].Clin Cancer Res, 1995,1(3) : 247-256.
  • 8Goldstein LJ, O'Neill A, Sparano J, et al. Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197[J].J Clin Oncol, 2008,26 (25) :4092-4099.
  • 9Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009[J]. Annals of Oncology, 2009,20(8) : 1319-1329.
  • 10Westenend PJ, Meurs CJ, Damhuis RA. Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis[J]. J Clin Pathol,2005,58(2) : 196-201.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部